Bacterial Pathogens and Diseases I Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

What is a pathogen?

A

A microorganism capable of causing disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Pathogenecity

A

the ability of an infectious agent/microorganism to cause disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Virulence

A

quantitative ability of an agent to cause disease

-degree of pathogenecity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Toxigenicity

A

the ability of a microorganism to produce a toxin that contributes to the development of the disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are virulence mechanisms?

A

Mechanisms that allow microorganisms to attach/proliferate:

  • Adherence factors
  • Biofilms
  • Invasion of host cells and tissues
  • Toxins (endotoxins & exotoxins)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are exotoxins?

A

Exotoxins are a heterogenous group of proteins produced and secreted by living bacterial cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What kind of bacteria are exotoxins produced by?

A

BOTH gram-negative and gram-positive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the effect of exotoxins?

A

They act via a variety of diverse mechanisms to cause tissue damage and result in disease symptoms in the host

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Why do bacteria produce exotoxins?

A

Gives them an evolutionary advantage by allowing for colonisation, niche establishment and carriage:

· Exotoxins may help transmission of disease, however in severe disease host may be a literal and evolutionary dead end. However, with many toxins the disease-causing activity may not be the primary function

· Evade immune response
· Enable biofilm formation
· Enable attachment to host cells
· Escape from phagosomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What kind of bacteria is Staphylococcus?

A

Gram positive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Exotoxins produced by Staphylococcus aureus

A

Haemolytic Toxins

  • Cause cells to lyse by forming pores → causing tissue damage
  • ⍺,β,ẟ toxins, Panton Valentine Leukocidin (PVL), LukAB, LukED, LukMF

Phenol Soluble Modulins (PSMs)
- cause damage to cells by interfering with the membrane structure- cause the lipid membrane of cells to become disaggregated→lysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

S.aureus in humans

A

Majority of S.aureus in humans is asymptomatic carriage in the nose existing as a commensal organism.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

In what form does S.aureus colonise the nose?

A

it colonises in a biofilm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is a biofilm?

A

communities of bacteria that exist as colonies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How is S.aureus able to survive as a commensal organism in humans?

A

Secretes exotoxins useful for colonisation:

  • e.g. haemolytic toxins to stop other organisms from growing (competition to establish itself in an environmental niche)
  • e.g. PSMs and S.aureus ⍺ which inhibit phagolysosome fusion, enabling bacteria to escape phagosome into the cytoplasm for intracellular niche establishment and replication
  • e.g. PSMs target cohabiting bacterial species, competing for resources and exclusion of non-kin isolates
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How is a S.aureus biofilm formed?

A

1) ⍺-toxin establishes cell-cell contacts, enabling the formation of secondary biofilm structures
2) Extracellular matrices develop, surrounding the cells within the biofilm. In the presence of extracellular DNA (eDNA), β-toxin covalently cross-links with itself, adding to this extracellular nucleoprotein biofilm matrix and contributing to the formation of the complex biofilm secondary structuring
3) PSMs detach from the mature biofilm, aiding in the release of cell clusters from the main body of the biofilm which allows for dispersal to new sites of infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are exotoxins encoded by?

A

Some by chromosomal genes:

  • Shiga toxin in Shigella dysenteriae
  • TcdA & TcdB in C.difficile

Many by extrachromosomal genes:
· Plasmids- bacillus anthracis toxin, tetanus toxin
· Lysogenic bacteriophage- e.g. streptococcal pyrogenic exotoxins in Scarlet Fever, Diphtheria toxin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Classification of exotoxins

A

Exotoxins are classified by their activity:

Membrane Acting Toxins (Type I)
Membrane Damaging Toxins (Type II)
Intracellular Toxins (Type III)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Why is classifying exotoxins by their activity problematic?

A

many toxins may have more than one type of activity

as mechanisms are better understood this classification tends to break down

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Membrane Acting Toxins- Type I

A

Toxins which act from the outside of the cell or on the membrane and interfere with intracellular host cell signalling by inappropriate activation of host cell receptors

-generates changes in the activity of the pores on the membrane, which can lead to disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Target receptors of membrane acting toxins (Type I)

A

Guanyly cyclase →↑cGMP activity

Adenylyl cyclase →↑cAMP activity

Rho proteins
Ras proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

MOA of Type I-E.coli Stable Heat Toxin

A

1) Exotoxin binds guanylyl cyclase C membrane receptor and causes an increase in cGMP production
2) cGMP then promotes further downstream signalling. It acts via protein kinases and a CFTR pump. This CFTR channel pumps out chloride and bicarbonate ions out of the cell.
3) The cGMP, via another mechanism, produces cAMP which then inhibits the pumps which pump out hydrogen and bring in sodium.
4) Net effect is you get chloride ions, bicarbonate ions and sodium chloride ions being pumped out of the cell. Where salt goes (sodium chloride), water follows, hence why you get diarrhoea from this infection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Membrane Damaging Toxins- Type II

A

cause damage to the host cell membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

How do membrane damaging toxins cause damage to the host cell membrane?

A

Receptor Mediated:

-Insert channels/pores into host cell membrane, disrupting homeostatic mechanisms (E.g. ion flux across membrane)
·β sheet toxins e.g. S.aureus ⍺-toxin, 𝛾-toxin, PVL
·⍺ helix toxins- e.g. diphtheria toxin

Receptor Independent:

  • Causes enzymatic damage
  • e.g. S.aureus β-haemolysin, PSMs
25
Q

Intracellular Toxins- Type III

A

Toxins which are active within the cell (must gain access to the cell)

26
Q

Structure of intracellular toxins (Type III)

A

Most of these toxins are proteins known as AB toxins because they usually have 2 components:

  • receptor binding and translocation function (B)
  • toxigenic/enzymatic (A)

*may be single or multiple B units e.g. Cholera toxin AB5

27
Q

How do intracellular AB toxins (type III) work?

A

1) B component of the toxin binds to the receptor and toxin is internalised inside the cell.
2) Once the toxin is internalised, it is cleaved by proteolytic degradation, releasing the active component of the toxin (A).
3) Active enzymatic component has a wide variety of activities, acting at multiple sites within the cytoplasm and causing damage

28
Q

what are some activities of enzymatic component A

A

ADP – ribosyl transferases - e.g. Exotoxin A of Pseudomonas aeruginosa, pertussis toxin.

Glucosyltransferases – e.g. TcdA and TcdB of Clostridium difficile

Deamidase – e.g. dermonecrotic toxin of Bordetella pertussis.

Protease – e.g. Clostridial neurotoxins: botulism & tetanus

Adenylcyclase - e.g. EF (Edema factor) toxin of Bacillus anthracis

29
Q

Type III toxins other than AB toxins

A

Type III secretion and toxin injection
-bacteria adheres to surface and injects effector proteins inside cells through a needle structure which penetrates the membrane of the host cell (e.g. YopE in Yersinia species)

Type IV secretion and toxin injection
-pumps in larger proteins (e.g. CagA in Helicobacter pylori)

30
Q

Effect of exotoxins on immunity

A

Exotoxins are able to induce inflammatory cytokine release, which causes damage to tissues.

  • IL1, IL1β, TNF, IL6, ẟ interferon, IL18
31
Q

How do exotoxins induce inflammatory cytokine release?

A

Superantigen (bacterial toxin)

  • cause non-specific bridging of the MHC Class II and T-cell receptor without any antigen presentation
  • clonal activation of T-cells, producing many different cytokines which drive inflammation and tissue damage
  • e.g. Staphylococcal Exfoliative Toxin A, Toxic Shock Syndrome Toxin 1 (TSST1)

Inflammasome
-exotoxin activates different inflammasomes leading to release of IL1β and IL18 e.g. S.aureas toxin A, PVL

32
Q

Toxoid

A

inactivated toxin

33
Q

How can toxins be inactivated to produce toxoids?

A

Toxins can be inactivated using formaldehyde or glutaraldehyde

34
Q

What are toxoids used for?

A

Toxoids are inactive proteins but still highly immunogenic- form the basis for vaccines:

· Tetanus vaccine
· Diphtheria vaccine
· Pertussis (acellular) vaccine

35
Q

Treatment of Toxin-Mediated Disease

A

Administering antibodies to the toxin:

  • Diphtheria antitoxin- horse antibodies
  • Tetanus antitoxin- pooled human immunoglobulin. Specific or normal
  • Botulism antitoxin- horse antibodies

Monoclonal antibodies are also used in experiments and research in the treatment of toxin mediated disease

36
Q

Bacteria which can cause toxin mediated disease include…

A

Clostridium difficile

Verocytotoxin/Shiga-toxin (Stx) producing Escherichia Coli (VTEC)(STEC)

37
Q

Microbiology of C.difficile

A
· Gram-positive bacillus (rod)
· Anaerobic
· Spore-forming
· Toxin-producing
· Can be carried asymptomatically in the gut
· Produces 3 toxins
38
Q

Epidemiology of C.difficile

A

· Common hospital acquired infection worldwide
· Spread by ingestion of spores (remain dormant in the environment) or spread from patient to patient
· Coloniser of the human gut up to 5% in adults
· Risk factors- antibiotic use, age (>60 years), antacids & prolonged hospital stay

39
Q

How do antibiotics cause C.difficile infection?

A

Antibiotics disrupt the microbial system within the gut, providing a competitive advantage to spore forming anaerobes over non-spore forming anaerobes
-allows C.difficile colonisation and growth

40
Q

Which antibiotics are likely to cause C.difficile infection?

A

Some antibiotics are worse than others

  • 2nd and 3rd generation cephalosporins
  • quinolones
  • clindamycin

Others less likely to cause C.difficile infection:

  • Aminoglycosides
  • Trimethoprim
  • Vancomycin
41
Q

What are the toxins produced by C.difficile?

A

Cytotoxin A
-TcdA coded by tcdA gene

Cytotoxin B
-TcdB coded by tcdB gene

Binary Toxin
-C.difficile transferase (minor role in disease)

42
Q

What kind of toxins are TcdA and TcdB?

A

Type III AB toxins

-A component are gycosylating enzymes

43
Q

MOA of TcdA and TcdB toxins

A

1) Toxins binding to specific host cell receptors and get into the cell through receptor mediated endocytosis
2) Toxins are internalised and packaged within an endosome
3) Endosome is acidified
4) Pore formation in the endosome
5) Pore allows for GTD release from the endosome to the host cell cytoplasm
6) There is Rho GTPase inactivation by glucosylation

7) This results in downstream effects within the host cell:
Cytopathic effects
>cytoskeleton breakdown
>loss of cell-cell contacts
>increased epithelial permeability

Cytotoxic effects
>activation of the inflammasome (more cytokine release causing damage)
>increase in ROS levels
>induction of programmed cell death

44
Q

What is the result of cytopathic & cytotoxic effect of C.difficile toxins?

A

· Patchy necrosis with neutrophil infiltration
· Epithelial ulcers
· Pseudomembranes over the ulcers- combination of leucocytes, fibrin, mucous, cell debris

45
Q

How can C.difficile disease present?

A

The C-difficile disease can range from:

  • Asymptomatic
  • water diarrhoea
  • dysentery (diarrhoea with blood and straining)
  • pseudomembranous colitis
  • toxic megacolon and peritonitis
46
Q

Diagnosis of C.difficile

A

Clinical signs and symptoms

Raised white cell count in blood

Detection of organisms and toxins in stool via 2 phase test:

1) Glutamate dehydrogenase- detects if C.difficile organism is present
2) Toxin enzyme linked immunosorbent assay (ELISA) for TcdA and TcdB toxins

Detection of tcdA and tcdB genes via PCR

Colonoscopy- pseudomembranous colitis

47
Q

Treatment of C.difficile

A

Treatment is dependent on severity and presence of surgical complications.

· Ideally, removal of offending antibiotic- not always possible
· Antibiotics fidaxomicin, metronidazole or vancomycin work against C.difficile
· Surgery- partial or total colectomy
· Recurrent C.difficile - treat with faecal transplant to re-establish the normal gut flora

48
Q

Shiga toxin-producing E. coli (STEC)

A

Stx is carried by some E.coli- most commonly O157:H7 (particular type of bacteria)

49
Q

Epidemiology of E.coli O157:H7

A

E.coli O157:H7 naturally colonises the gastrointestinal tracts of cattle who are generally asymptomatic

· Transmission of E.coli:

  • predominantly via consumption of contaminated food and water
  • person to person, particularly in child day-care facilities
  • animal to person e.g. in petting zoos, dairy farms or camp grounds

· Very low infectious dose needed to cause infection (meaning it is quite infectious)

50
Q

Toxin produced by E.coli O157:H7

A
  • Toxin: Shiga like toxin (SLT)= shigatoxin (Stx)= verocytotoxin (VTEC)
  • Stx, Stx1, Stx1a, 1c, 1d, Stx2a, 2c, 2d- variations in amino acid sequence
  • Gene carried on lysogenic phage
51
Q

Structure of Shiga toxin

A
  • Type III exotoxin- AB5
  • Enzymatic component A= N-Glycosidase
  • Bound to 5 B subunits
52
Q

MOA of Shiga toxin (Stx)

A

· Toxin binds to receptor Gb3 or Gb4 on host cell membrane
· Bound toxin internalised by receptor mediated endocytosis
· Carried by retrograde trafficking via the Golgi apparatus to the endoplasmic reticulum
· The A subunit is cleaved off by membrane bound proteases
· Once in the cytoplasm A1 and A2 disassociated
· A1 binds to 28S RNA subunit→blocks protein synthesis

53
Q

Pathogenesis of STEC

A
  • STEC closely adheres to the epithelial cells of the gut mucosa
  • Stx is transported from the intestine to the kidney and other tissues via polymorphonuclear neutrophils (PMNs); but this is debated
  • Bind to glomerular endothelial cells of kidney, cardiovascular and central nervous system
  • Very high levels of Gb3 in kidney so kidneys most affected
  • Thought that Stx favours inflammation resulting in microvascular thrombosis and inhibition of fibrinolysis (damaging the kidney)
54
Q

Presentation of STEC Disease

A

· Abdominal cramps, watery or bloody diarrhoea- may not be present

· Haemolytic uraemic syndrome presentation
>anaemia
>renal failure
>thrombocytopaenia

· Less common are neurological symptoms
>lethargy
>severe headache
>convulsions
>encephalopathy
55
Q

Severity of STEC Disease

A

· Can be severe and life threatening

Often in children <5 years are at greatest risk

56
Q

Diagnosis of STEC Disease

A
  • Clinical signs and symptoms
  • Haematological and biochemical evidence
  • Stool culture- growth on SMac
  • PCR for Stx genes
57
Q

How can we identify STEC on a culture?

A

Stx is identified usually by growth on sorbital MacConkey agar (SMac)

O157:H7 does not ferment sorbitol and hence is red

58
Q

Treatment of STEC Disease

A
  • Supportive including renal dialysis and blood product transfusion
  • Antibiotics have little to no role